Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines

Brunella Grigolo, Gina Lisignoli, Stefania Toneguzzi, Ilaria Mazzetti, Andrea Facchini

Research output: Contribution to journalArticle

Abstract

Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

Original languageEnglish
Pages (from-to)1175-1180
Number of pages6
JournalAnticancer Research
Volume18
Issue number2 A
Publication statusPublished - Mar 1998

Fingerprint

Osteosarcoma
Superoxide Dismutase
Zinc
Copper
Cell Line
Neoplasms
Enzymes
Stromal Cells
Carcinogenesis
Oxidative Stress
Antioxidants
Cytokines

Keywords

  • Osteosarcoma cells
  • Oxgen antioxidant

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines. / Grigolo, Brunella; Lisignoli, Gina; Toneguzzi, Stefania; Mazzetti, Ilaria; Facchini, Andrea.

In: Anticancer Research, Vol. 18, No. 2 A, 03.1998, p. 1175-1180.

Research output: Contribution to journalArticle

Grigolo, B, Lisignoli, G, Toneguzzi, S, Mazzetti, I & Facchini, A 1998, 'Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines', Anticancer Research, vol. 18, no. 2 A, pp. 1175-1180.
Grigolo, Brunella ; Lisignoli, Gina ; Toneguzzi, Stefania ; Mazzetti, Ilaria ; Facchini, Andrea. / Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines. In: Anticancer Research. 1998 ; Vol. 18, No. 2 A. pp. 1175-1180.
@article{d129adf47bf944039b93857e050ad196,
title = "Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines",
abstract = "Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.",
keywords = "Osteosarcoma cells, Oxgen antioxidant",
author = "Brunella Grigolo and Gina Lisignoli and Stefania Toneguzzi and Ilaria Mazzetti and Andrea Facchini",
year = "1998",
month = "3",
language = "English",
volume = "18",
pages = "1175--1180",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 A",

}

TY - JOUR

T1 - Copper/zinc superoxide dismutase expression by different human osteosarcoma cell lines

AU - Grigolo, Brunella

AU - Lisignoli, Gina

AU - Toneguzzi, Stefania

AU - Mazzetti, Ilaria

AU - Facchini, Andrea

PY - 1998/3

Y1 - 1998/3

N2 - Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

AB - Oxidative stress has been frequently implicated in the initiation and promotion phases of carcinogenesis. Antioxidant enzymes, which can antagonize this process, are lowered in a number of malignancies even though different findings have been reported in the literature. It has been shown that tumors have less copper/zinc superoxide dismutase (Cu/Zn SOD) in comparison with the more metabolically active tissues, but there is a large overlap between normal and tumor tissue. In order to examine the relationship between ostosarcoma at different degrees of proliferation and differentiation and Cu/ZN SOD levels, four different human osteosarcoma cell lines: HOS, U-2 OS, MG63, Saos-2 were studied for their production and release of Cu/ZN SOD. A normal human stromal cell line was used as control. Osteosarcoma cells were stimulated with TNF α, a cytokine previously shown to have antiproliferative activity. The release of Cu/ZN SOD into the supernatant was higher for the HOS and U-2 OS lines when compared to the other cell lines evaluated both in basal condition and after incubation with TNF α. Elevated intracellular levels of Cu/ZN SOD were shown except for the HOS and U-2 OS which possess high concentrations of the enzyme at 24 hours declining during the other incubation periods. These concentrations were increased after TNF α treatment. The different behaviour of the four cell lines evaluated might be explained by their degree of differentiation.

KW - Osteosarcoma cells

KW - Oxgen antioxidant

UR - http://www.scopus.com/inward/record.url?scp=0031812110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031812110&partnerID=8YFLogxK

M3 - Article

C2 - 9615784

AN - SCOPUS:0031812110

VL - 18

SP - 1175

EP - 1180

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 A

ER -